San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

XIFIN Names James C. Malone Its New CFO

XIFIN Inc., a San Diego-based software and services company dedicated to optimizing the economics of health care, has named James C. Malone as its new chief financial officer.

Ligand Pharmaceuticals Reports 2014 Net Income of $12 Million

Ligand Pharmaceuticals Inc. reported net income of $12 million for the 2014 fiscal year, according to a recent regulatory filing.

Elcelyx Therapeutics Raises $5.8 Million in Financing

Elcelyx Therapeutics Inc., a biotechnology firm developing drugs for weight management and obesity-related metabolic disorders, has raised $5.8 million in a Series D financing round, according to a recent filing with the Securities and Exchange Commission.

Tease photo

AMN Healthcare Reports Q4 Net Income of $10 Million

The San Diego-based staffing company AMN Healthcare Services Inc. reported fourth-quarter net income of $10 million and net income per diluted share of $0.20. As a result, its stock increased nearly 14 percent to $22.96 per share.

Supreme Court Case Could Dismantle Health Care Law

Health Care Column

A looming Supreme Court case has put pressure on Congressional Republicans to design a new plan to replace President Obama’s signature health care law. But rather than develop new solutions, lawmakers seem to be producing more of the same. Out with the old, and… well, back in with the old.

Tease photo

Bastyr Fills Niche for Naturopathic Doctors

MEDICINE: Accredited School Is Seeing Increasing Enrollment

A new university in San Diego is training the next generation of primary care doctors in the state’s first and only accredited natural medicine school — Bastyr University.

Tease photo

OCTANe's CEO to Join UCSD Healthcare System

Matthew Jenusaitis will step down as president and chief executive officer of Aliso Viejo-based OCTANe to join the University of California San Diego Healthcare System.

Neurocrine Announces $225 Million Public Stock Offering

San Diego-based Neurocrine Biosciences Inc. has begun an underwritten public offering of shares of its common stock to raise aggregate proceeds of about $225 million.

Regen BioPharma Appoints Todd Caven CFO

Todd Caven has been appointed the new chief financial officer of Regen BioPharma Inc., a La Mesa-based biotechnology company focused on identifying undervalued regenerative medicine applications in the immunotherapy and stem cell space.

Bob Baltera Named CEO of Laguna Pharmaceuticals

La Jolla-based Laguna Pharmaceuticals, previously known as ChanRx, announced Tuesday the appointment of Bob Baltera as chief executive officer and the completion of a $30 million Series B financing.

Tease photo

German Court Sides With ResMed in Patent Infringement Case

A German court has upheld an injunction barring the Chinese medical device manufacturer BMC Medical Co. from offering, selling or distributing its sleep mask products on grounds that they infringe on patents held by San Diego’s ResMed Inc.

IriSys Raises $6.3 Million in Equity Financing

San Diego-based IriSys LLC has raised $6.3 million in equity financing, according to a recent filing with the Securities and Exchange Commission.

Consortium Formed to Develop Program to Fight Ebola

Scripps Translational Science Institute (STSI) announced Friday that it will lead a consortium of four partners to develop a program to improve health outcomes for Ebola patients, increase the safety of health care workers and reduce the risk of spreading the virus to others.

Tease photo

North County Health Services Completes Expansion of Oceanside Campus

North County Health Services announced Thursday the completion of a $5 million overhaul of its Mission Mesa campus in Oceanside. The project, which broke ground in December of 2013, quadrupled the size of the community clinic.

Molecular Response Sells Business Unit to Crown Biosciences

San Diego-based Molecular Response LLC announced Thursday the sale of one of its business units to Santa Clara-based Crown Biosciences Inc.